A research project investigating at how individuals with Type 2 Diabetes Mellitus respond to the addition of Sodium-glucose Cotransporter-2(SGLT2) inhibitor drugs in terms of blood sugar levels and weight.
Not Applicable
Completed
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/06/054440
- Lead Sponsor
- Dr Mahima Makhija
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
1.Patients >18 years of age.
2.Patients of Type 2 DM fulfilling criteria of Type 2 DM according to American Diabetes Association (ADA) guidelines.
3.Patients with Type 2 DM on other OHAs.
4.T2DM Patients with other Chronic Cardiovascular issues like HTN, Heart Failure and CAD
Exclusion Criteria
1.Patients with eGFR <60 mL/min/1.73m2.
2.Pregnant females.
3.Patients not filling the criteria of Type 2 DM according to ADA guidelines.
4.Patients with other contraindications to SGLT2 Inhibitors.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method